Otology & Neuerotology2026年9月17日

散發性前庭神經鞘瘤患者聽力功能監測:為未來隨機對照試驗提供依據的可行性研究

// Monitoring Hearing Function in Patients With Sporadic Vestibular Schwannoma: A Feasibility Study to Inform a Future Randomized Controlled Trial

非隨機單中心可行性研究:招募44人、31人入組(22 WW觀察、9 SRS),25人完成(80%),平均評估1小時42分|受損耳4F‑PTA:WW 42±14 dB HL vs SRS 55±9.4 dB;antiphasic DiN‑SRT50:WW −14.2±4.1 vs SRS −11.6±1.9 dB SNR,兩者高度相關(P<0.001)|結論:招募、留存與測試完成度足以推進決定性RCT,並提供樣本數估算所需變異數。

// This feasibility study tested whether a definitive RCT comparing upfront stereotactic radiosurgery (SRS) versus watch‑and‑wait (WW) for hearing preservation in vestibular schwannoma is practical, using a nonrandomized prospective single‑centre design with audiometric and patient‑reported measures. Of 44 recruited, 31 (22 WW, 9 SRS) met criteria and 25 (80%) completed all tests; mean assessment time was 1 h 42 min. Mean 4‑frequency PTA in affected ears was 42 ± 14 dB HL (WW) versus 55 ± 9.4 dB HL (SRS), antiphasic DiN‑SRT50 was −14.2 ± 4.1 dB SNR (WW) versus −11.6 ± 1.9 dB SNR (SRS), and 4FAPTA correlated with antiphasic DiN‑SRT50 (P < 0.001). The study concludes recruitment, retention, and test completion are sufficient to proceed to an RCT and provides variance estimates for sample‑size calculation.

Published 2026年9月11日

RELATED

// 正在尋找相關文獻...